Detection and Localization of Prostate Cancer With the Targeted Biopsy Strategy Based on ADC Map: A Prospective Large-Scale Cohort Study

To investigate the usefulness of targeted biopsy strategy based on apparent diffusion coefficient (ADC) maps in the detection and localization of prostate cancer.

[1]  M. Rubin,et al.  Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen , 2006, World Journal of Urology.

[2]  A. Prando.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume , 2009 .

[3]  K. Sugimura,et al.  Benign prostatic hyperplasia: value of MR imaging for determining histologic type. , 1994, Radiology.

[4]  S. Bott,et al.  Anterior prostate cancer: is it more difficult to diagnose? , 2002, BJU international.

[5]  C. Amling,et al.  Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. , 2000, The Journal of urology.

[6]  G. Haas,et al.  Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer , 2009, BJU international.

[7]  A S Whittemore,et al.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.

[8]  T. Sone,et al.  Age‐related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues , 2008, Journal of magnetic resonance imaging : JMRI.

[9]  W. Ellis,et al.  Improved prostate cancer detection with anterior apical prostate biopsies. , 2006, Urologic oncology.

[10]  Peter Guion,et al.  Initial clinical experience with real‐time transrectal ultrasonography‐magnetic resonance imaging fusion‐guided prostate biopsy , 2008, BJU international.

[11]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.

[12]  Amit Patel,et al.  Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. , 2006, The Journal of urology.

[13]  W. Ellis,et al.  Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. , 1994, The Journal of urology.

[14]  Evis Sala,et al.  Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.

[15]  Hiroshi Honda,et al.  Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology , 2008, Journal of magnetic resonance imaging : JMRI.

[16]  G. Haas,et al.  Saturation biopsies for prostate cancer: current uses and future prospects , 2009, Nature Reviews Urology.

[17]  Susanne Hempel,et al.  Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. , 2006, The Journal of urology.

[18]  Silvia D. Chang,et al.  Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology , 2006, Journal of magnetic resonance imaging : JMRI.

[19]  J Kurhanewicz,et al.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.

[20]  H. Shinmoto,et al.  Prostate cancer screening: The clinical value of diffusion‐weighted imaging and dynamic MR imaging in combination with T2‐weighted imaging , 2007, Journal of magnetic resonance imaging : JMRI.

[21]  T. Ishimori,et al.  Determination of the cutoff level of apparent diffusion coefficient values for detection of prostate cancer , 2011, Japanese Journal of Radiology.

[22]  P. Schellhammer,et al.  The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies. , 2002, Clinical prostate cancer.

[23]  Jason A Koutcher,et al.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.

[24]  Hedvig Hricak,et al.  Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[25]  M. Kattan,et al.  Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. , 2005, The Journal of urology.

[26]  Nicolas Barry Delongchamps,et al.  Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. , 2007, Journal of the National Cancer Institute.

[27]  A. D'Amico,et al.  Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. , 2006, The Journal of urology.